U.S., July 23 -- ClinicalTrials.gov registry received information related to the study (NCT07718867) titled 'Point-of-care Capillary HbA1c Testing for Type 2 Diabetes Screening Among At-risk Individuals in Rural Dali, China' on July 13.

Brief Summary: This project aims to compare Point-of-care capillary HbA1c (POC-cHbA1c) testing and fingerstick random blood glucose (RBG) testing in terms of type 2 diabetes detection rate and cost-effectiveness, in order to optimise current screening strategies for rural populations at high risk of diabetes in rural Dali, China, and to improve treatment adherence and self-management among people with diabetes.

Study Start Date: Aug. 01

Study Type: INTERVENTIONAL

Condition: Type 2 Diabetes Pre-diabetes...